Woom Fertility
WOOM is a data model driven startup to empower women to maximize chances of pregnancy either natural or through medical treatment.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 693 % | 780 % | (60 %) | 50 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (7322 %) | (1194 %) | (31 %) | (489 %) | (459 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (7758 %) | (1261 %) | (50 %) | (618 %) | (585 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Woom Fertility operates as a data-driven enterprise in the femtech sector, focused on women's reproductive health. The company was established in Madrid, Spain, in 2015 by co-founders Clelia Morales and Laurence Fontinoy. Drawing from their previous executive experiences at Google and eBay, the founders aimed to create a trusted, data-centric resource for women based on their personal journeys to motherhood.
The core of Woom's offering is a mobile application that functions as a sophisticated period and fertility tracker. It utilizes machine learning algorithms to analyze over 100 parameters, including a woman's menstrual cycle, biometric data, and lifestyle factors, to calculate daily pregnancy probabilities. This helps users optimize their chances of natural conception or guides them toward seeking specialist advice sooner. Beyond fertility, the platform provides personalized content and support for all stages of a woman's reproductive life, from contraception through to menopause. The app also fosters a large community, primarily in Spanish-speaking countries, where users can share experiences and advice.
The company's business model has both B2C and B2B components. For consumers, the app provides personalized health tracking and community access. On the B2B side, Woom collaborates with corporations, such as insurance giant MAPFRE and Ferring Pharmaceuticals, to offer its services to their clients and to provide valuable data insights. Having raised approximately €4.88M in funding through multiple rounds, Woom demonstrated significant traction, registering over 1.8 million users and 156,000 pregnancies by 2022. This success culminated in its acquisition in May 2022 by Apricity, a virtual fertility clinic, to create an integrated digital fertility pathway from conception tracking to clinical treatment.
Keywords: femtech, reproductive health, fertility tracking, ovulation calculator, period tracker, machine learning, data-driven health, conception aid, women's health technology, fertility app, digital health, pregnancy support, menstrual cycle, B2B health solutions, community support, virtual fertility, AI health, personalized health insights, MAPFRE partnership, Apricity acquisition